Rachel King, GlycoMimetics, Inc. (GMI) (EP.08)

Rachel K. King, co-founder and CEO of GlycoMimetics, Inc. (GMI), joins Rich Bendis to discuss being the CEO of a publicly traded clinical-stage biotechnology company, gene therapy, and the BioHealth Capital Region.

Episode metadata supplied by the publisher feed · Published Feb 19, 2018

Embed this episode

Attribution link and audio player

NOW PLAYING

Rachel King, GlycoMimetics, Inc. (GMI) (EP.08)

0:00 31:24

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Wild WinsDay Wild WinsDay Pump the hump with WILD WINSday 🐪💪: Your 3-minute weekly video boost for leadership, sales, marketing, and business breakthroughs to WIN the day!

Frequently Asked Questions

How long is this episode of BioTalk with Rich Bendis?

This episode is 31 minutes long.

When was this BioTalk with Rich Bendis episode published?

This episode was published on February 19, 2018.

Can I download this BioTalk with Rich Bendis episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!